Phase IV-Cervical Dystonia-INTEREST IN CD2

• Status: Active, not recruiting
• Trial end date: 0000-00-00
• Target enrollment: 1050
• Participant gender: Both

Summary

The purpose of the study is to document long-term response in real-life practice after injection cycles with BoNT-A in subjects suffering from idiopathic cervical dystonia (Long-term clinical and pharmaco-economic data).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ipsen
• Treatments: incobotulinumtoxinA
• Last Updated: 2016-09-30

Criteria

Inclusion Criteria:

• Subject for whom there is an intention to treat with BoNT-A.

• BoNT treatment naïve or previously treated with BoNT.

• If previously treated with BoNT, at least a 12-week interval between the last injection (BoNT-A or BoNT-B) and inclusion.

• Subject able to comply with the protocol.

• Provision of written informed consent prior to collect the data.

Exclusion Criteria:

• Contraindications to any BoNT-A preparations.

• The subject has already been included in the study.